Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism

Clinical Cancer Research

Volumn 9, Issue 3, 2003, Pages 1009-1012

  Liu, Wanqing ^a   Innocenti, Federico ^a   Chen, Peixian ^a   Das, Soma ^a   Cook Jr , Edwin H ^a   Ratain, Mark J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ALLELE; ARTICLE; ASIA; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; INTRONS; POLYMORPHISM, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0037339858     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Herbst, R. S., and Langer, C. J. Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers. Semin. Oncol., 29(Suppl. 4): 27-36, 2002.
2. Lacroix, H., Iglehart, J. D., Skinner, M. A., and Kraus, M. H. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene, 4: 145-151, 1989.
3. Klijn, J. G., Berns, P. M., Schmitz, P. I., and Foekens, J. A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev., 13: 3-17, 1992.
4. Veale, D., Kerr, N., Gibson, G. J., Kelly, P. J., and Harris, A. L. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br. J. Cancer, 68: 162-165, 1993.
5. Glynne-Jones, E., Goddard, L., and Harper, M. E. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue. Hum. Pathol., 27: 688-694, 1996.
6. Volm, M., Rittgen, W., and Drings, P. Prognostic value of ERBB-1. VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br. J. Cancer, 77: 663-669, 1998.
7. Fischer-Colbrie, J., Witt, A., Heinzl, H., Speiser, P., Czerwenka, K., Sevelda, P., and Zeillinger, R. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res., 17: 613-619, 1997.
8. Niikura, H., Sasano, H., Sato, S., and Yajima, A. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors. Int. J. Gynecol. Pathol., 16: 60-68, 1997.
9. Neskovic-Konstantinovic, Z., Nikolic-Vukosavljevic, D., Brankovic-Magic, M., Kanjer, K., Gavrilovic, D., Mitrovic, L., Borojevic, N., Vukotic, D., and Spuzic, I. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease. J. Exp. Clin. Cancer Res., 18: 347-355, 1999.
10. Ohsaki, Y., Tanno, S., Fujita, Y., Toyoshima, E., Fujiuchi, S., Nishigaki, Y., Ishida, S., Nagase, A., Miyokawa, N., Hirata, S., and Kikuchi, K. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol. Rep., 7: 603-607, 2000.
11. Nicholson, R. I., Gee, J. M., and Harper, M. E. EGFR and cancer prognosis. Eur. J. Cancer 37(Suppl. 4): S9-S15, 2001.
12. Wu, X., Fan, Z., Masui, H., Rosen, N., and Mendelsohn, J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. Clin. Investig., 95: 1897-905, 1995.
13. Liu, B., and Fan, Z. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway. Oncogene, 20: 3726-3734, 2001.
14. Ciardiello, F., and Tortora, G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin. Cancer Res., 7: 2958-2970, 2001.
15. Chan, K. C., Knox, W. F., Gee, J. M., Morris, J., Nicholson, R. I., Potten, C. S., and Bundred, N. J. Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast. Cancer Res., 62: 122-128, 2002.
16. Ciardiello, F., and Tortora, G. Anti-epidermal growth factor receptor drugs in cancer therapy. Expert Opin. Investig. Drugs, 11: 755-768, 2002.
17. Fukuoka, M., Yano, S., Giaccone, G., Tamura, T., Nakagawa, K., Douillard, J. Y., Nishiwaki, Y., Vansteenkiste, J. F., Kudo, S., Averbuch, S., Macleod, A., Feyereislova, A., and Baselga, J. Final results from a phase II trial of ZD1839 ('Iressa') for patients with advanced non-small-cell lung cancer (IDEAL 1). Proc. Am. Soc. Clin. Oncol., 21: 298a, 2002.
18. Chi, D. D., Hing, A. V., Helms, C., Steinbrueck, T., Mishra, S. K., and Donis-Keller, H. Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and pro α 2 (I) collagen (COL1A2). Hum. Mol. Genet., 1: 135, 1992.
19. Gebhardt, F., Zanker, K. S., and Brandt, B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J. Biol. Chem., 274: 13176-13180, 1999.
20. Buerger, H., Gebhardt, F., Schmidt, H., Beckmann, A., Hutmacher, K., Simon, R., Lelle, R., Boecker, W., and Brandt, B. Length and loss of heterozygosity of an intron 1 polymorphic sequence of EGFR is related to cytogenetic alterations and epithelial growth factor receptor expression. Cancer Res., 60: 854-857, 2000.
21. Liu, W., Wang, H., Zhao, S., Zhao, W., Bai, S., Zhao, Y., Xu, S., Wu, C., Huang, W., Chen, Z., Feng, G., and He, L. The novel gene locus for agenesis of permanent teeth (He-Zhao deficiency) maps to chromosome 10q11.2. J. Dent. Res., 80: 1716-1720, 2001.
22. Evans, W. E., and Relling, M. V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science (Wash. DC), 286: 487-491, 1999.
23. Marsh, S., Collie-Duguid, E. S., Li, T., Liu, X., and McLeod, H. L. Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics, 58: 310-312, 1999.
24. Marsh, S., Ameyaw, M. M., Githang'a, J., Indalo, A., Ofori-Adjei, D., and McLeod, H. L. Novel thymidylate synthase enhancer region alleles in African populations. Hum. Mutat., 16: 528, 2000.
25. Mcleod, H., and Ameyaw, M. Ethnicity and pharmacogenomics. In: J. Licinio and M-L. Wong (eds.), Pharmacogenomics: The Search for Individualized Therapies. Weinheim: Wiley-Vach., 489-514, 2002.
26. Cohen, E., Rosen, F., Dekker, A., Bajda, C., Stenson, K., Shulman, K., Lamont, E., Kozloff, M., and Vokes, E. Phase II study of ZD1839 (Iressa) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Proc. Am. Soc. Clin. Oncol., 21: 225a, 2002.
27. Carpenter, G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem., 56: 881-914, 1987.
28. Merlino, G. T., Ishii, S., Whang-Peng, J., Knutsen, T., Xu, Y. H., Clark, A. J., Stratton, R. H., Wilson, R. K., Ma, D. P., Roe, B. A., et al. Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol. Cell. Biol., 5: 1722-1734, 1985.
29. Merlino, G. T., Xu, Y. H., Richert, N. Clark, A. J., Ishii, S., Banks-Schlegel, S., and Pastan, I. Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line. J. Clin. Investig., 75: 1077-1079, 1985.
30. Zhang, W., Stoehlmacher, J., Park, D. J., Groshen, S., Tsao-Wei, D., Zahedy, S., Lu, B., Gil, J., Mallik, N., and Lenz, H-J. A polymorphic dinucleotide repeat in intron 1 of EGFR (epithelial growth factor receptor) gene is associated with clinical response to platinum based chemotherapy in patients with advanced colorectal disease. Proc. Am. Soc. Clin. Oncol., 21: 134a, 2002.